Hepquant
HepQuant is a Denver-based company specializing in non-invasive, blood-based quantitative tests designed to assess liver health and aid healthcare providers in managing patients with liver disease. Their innovative HepQuant DuO test delivers a Disease Severity Index (DSI), enabling clinicians to make informed decisions about patient care, treatment efficacy, and risk assessment for advanced liver conditions.
The company addresses the critical issues surrounding liver disease, which affects an estimated 30 to 40 percent of Americans, by providing tools that empower healthcare professionals to monitor disease progression and treatment responses effectively. HepQuant is committed to advancing liver health management through continuous innovation and participation in clinical trials, ensuring a robust impact on patient outcomes.
Generated from the website